lopinavir/ritonavir did not shorten the duration of sars cov-2 shedding in patients with mild pneumonia in taiwan. ¬© 2020An increase of Ct values was 0.9 per day in 2 cases of COVID-19 treated with lopinavir/ritonavir (LPV/r), an increase was 1.0 per day in 3 cases without LPV/r through illness day 1‚Äì10, indicating that LPV/r did not shorten the duration of SARS CoV-2 shedding.